For how we live.
One drug, dapoxetine, is purpose-approved for it, and not in the US. An umbrella review of 65 trials found the SSRIs and anaesthetics that lengthen latency rest on weak evidence.
The largest meta-analysis puts the incidence attributable to the drug at about 15% — one in six or seven. Critics who reanalysed part of it put it above 50%. The gap is about what counts as evidence.
Pooling 151 studies and 58,534 participants across 30 drugs, researchers ranked antidepressants by physiological side effects rather than efficacy. Some drugs raised cholesterol while reducing body weight.